share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer SUSMAN SALLY

SEC announcement ·  Feb 29 06:14
Summary by Futu AI
Sally Susman, Executive Vice President at Pfizer Inc. [PFE], was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and total value of shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Susman after the action. This transaction is part of the routine disclosures that executive officers are required to make and could be of interest to investors following Pfizer's stock.
Sally Susman, Executive Vice President at Pfizer Inc. [PFE], was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and total value of shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Susman after the action. This transaction is part of the routine disclosures that executive officers are required to make and could be of interest to investors following Pfizer's stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.